featured
Association Between GLP-1 Receptor Agonist Therapy and the Risk of Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials
Diabetes Obes Metab 2023 Nov 29;[EPub Ahead of Print], GA Silverii, M Monami, M Gallo, A Ragni, F Prattichizzo, V Renzelli, A Ceriello, E MannucciFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.